A Prospective, Comparative Study of the Occurrence and Severity of Constipation with Darifenacin and Trospium in Overactive Bladder

A Prospective, Comparative Study of the Occurrence and Severity of Constipation with Darifenacin and Trospium in Overactive Bladder

Introduction: Darifenacin and trospium are the commonly used antimuscarinics in the management of overactive bladder (OAB). Constipation is the second most common treatment related sideeffect. Though its incidence with the above two medications is known, data on their comparative severity and imp...

Full description

Bibliographic Details
Main Authors:	Revanna Manjunatha, Hulikallu Purushotama Pundarikaksha, Basavanahalli Krishnaiah Hanumantharaju, Satenahalli Javaregowda Anusha
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2015-03-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	antimuscarinics bristol stool form scale cas kess
Online Access:	https://jcdr.net/articles/PDF/5677/11884_CE(RA1)_F(T)_PF1(PAK)_PFA(AK)_PF2(PAG)_u.pdf

Similar Items

Normal Bowel Pattern in Children and Dietary and Other Precipitating Factors in Functional Constipation
by: Balamma Sujatha, et al.
Published: (2015-06-01)

Impact of COVID-19 quarantines on clozapine-induced constipation: Experience of utilizing a clozapine-induced constipation protocol at a state forensic psychiatric facility
by: Bridgette M. Gleisner, PharmD, et al.
Published: (2024-02-01)

The Importance of Objective Stool Classification in Fecal 1H-NMR Metabolomics: Exponential Increase in Stool Crosslinking Is Mirrored in Systemic Inflammation and Associated to Fecal Acetate and Methionine
by: Leon Deutsch, et al.
Published: (2021-03-01)

Adaptation and validation of the Bristol scale stool form translated into the Spanish language among health professionals and patients Adaptación y validación de las escalas de Bristol a la lengua española por profesionales sanitarios y pacientes
by: D. Parés, et al.
Published: (2009-05-01)

A cross‐sectional study of stool form (using Bristol stool chart) in an urban South Indian population
by: Melpakkam Srinivas, et al.
Published: (2019-12-01)

Resistant potato starches (type 4 RS) exhibit varying effects on laxation with and without phylum level changes in microbiota: A randomised trial in young adults
by: W.J. Dahl, et al.
Published: (2016-05-01)

Solifenacin and Tolterodine are Equally Effective in the Treatment of Overactive Bladder Symptoms
by: Chen-Hsun Ho, et al.
Published: (2010-10-01)

Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment
by: Aram Kim, et al.
Published: (2017-01-01)

Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
by: Luisa Gracio Ferreira Sartori, et al.
Published: (2023-08-01)

Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study
by: Daigo Kamei, et al.
Published: (2020-01-01)

Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader‐Willi Syndrome: A randomized, double‐blind, crossover trial
by: Zainab Alyousif, et al.
Published: (2020-12-01)

The Effectiveness of Anticholinergic Therapy for Overactive Bladders: Systematic Review and Meta-Analysis
by: Andrea Moura Rodrigues Maciel da Fonseca, et al.
Published: (2016-11-01)

Re: Bhide AA et al. Bladder contractility index changes with short-term antimuscarinic therapy in patients with detrusor overactivity: A placebo controlled randomised study. Continence 8 (2023) 101047
by: Juan Pablo Valdevenito, et al.
Published: (2024-03-01)

A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain
by: Jameel Nazir, et al.
Published: (2018-09-01)

Efficacy of trospium for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study
by: Vinit Kumar Srivastava, et al.
Published: (2020-04-01)

Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain
by: Peral C, et al.
Published: (2016-09-01)

Adherence to Overactive Bladder Syndrome Treatments Recent Developments and Future Perspectives
by: Robinson D, et al.
Published: (2023-05-01)

Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review
by: Vozmediano-Chicharro R, et al.
Published: (2020-08-01)

What to Do and What Not to Do in the Management of Opioid-Induced Constipation: A Choosing Wisely Report
by: Domenico Alvaro, et al.
Published: (2020-09-01)

Entre hybridité et univocité culturelles : aspects du multiculturalisme britannique à Bristol
by: Vincent Latour

Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer
by: Löfling L, et al.
Published: (2019-01-01)

Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?
by: Ömer Acar, et al.
Published: (2019-06-01)

Therapeutic efficacy of probiotic Alkalihalobacillus clausii 088AE in antibiotic-associated diarrhea: A randomized controlled trial
by: Chiranjit Maity, et al.
Published: (2021-09-01)

Postoperative Assessment of the Quality of Life in Patients with Colorectal Endometriosis
by: Claudia Mehedintu, et al.
Published: (2021-11-01)

Celiac Disease in Uzbek Children: Insights into Disease Prevalence and Clinical Characteristics in Symptomatic Pediatric Patients
by: Altinoy T. Kamilova, et al.
Published: (2023-09-01)

Clinical significance and related factors of rectal hyposensitivity in patients with functional defecation disorder
by: Ya Jiang, et al.
Published: (2023-02-01)

Comparative study of different combinations of mirabegron and antimuscarinics in treatment for overactive bladder syndrome in elderly patients
by: Yuh-Chen Kuo, et al.
Published: (2023-01-01)

The experience of using fesoterodine in patients with overactive bladder in the older age group
by: Elena I. Ermakova
Published: (2020-05-01)

Effect of Antimuscarinic Drugs on Cognitive Functions in the Management of Overactive Bladder in Elderly
by: Ervandy Rangganata, et al.
Published: (2020-10-01)

Constipation - a patient's discomfort or a disturbing symptom - an overview of current knowledge
by: Daria Kuziemkowska, et al.
Published: (2023-09-01)

Corrigendum: Understanding Adolescents' Perceptions of Diarrhea: A Formative Research Study of a Visual Scale to Measure Self-Reported Diarrhea in Low-Resource Settings
by: Anise Gold-Watts, et al.
Published: (2021-10-01)

Understanding Adolescents' Perceptions of Diarrhea: A Formative Research Study of a Visual Scale to Measure Self-Reported Diarrhea in Low-Resource Settings
by: Anise Gold-Watts, et al.
Published: (2021-05-01)

‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’
by: IQBAL SINGH, et al.
Published: (2015-06-01)

Therapeutic efficacy and cognitive adverse events of overactive bladder medication in patients with central nervous system Disorders—A cohort study
by: Sheng-Fu Chen, et al.
Published: (2022-10-01)

Exploring Concomitant Acetylcholinesterase Inhibitor and Overactive Bladder Anticholinergic Use and Risk of Hospitalization in Medicare and Dual-Eligible Medicare–Medicaid Populations in a Historic Database
by: Jonathan H. Watanabe, et al.
Published: (2023-09-01)

Study design of a phase 4, real-world study (COMPOSUR) to evaluate vibegron in patients with overactive bladder
by: Roger R. Dmochowski, et al.
Published: (2023-04-01)

Overactive bladder in an integrated delivery system: a longitudinal cohort study
by: Jeffrey A. Linder, et al.
Published: (2020-05-01)

Bladder contractility index changes with short-term antimuscarinic therapy in patients with detrusor overactivity: A placebo controlled randomised study
by: Alka Ashok Bhide, et al.
Published: (2023-12-01)

The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis
by: Ohtaki Yuichiro, et al.
Published: (2022-08-01)

Protective Effects of Antimuscarinics on the Bladder Remodeling After Bladder Outlet Obstruction
by: Qiang Liu, et al.
Published: (2017-11-01)